Caricamento...
Physostigmine for dementia due to Alzheimer's disease
BACKGROUND: The main pharmacological approach for the treatment of Alzheimer's disease (AD) has been based on the use of agents potentiating cholinergic transmission, particularly by inhibiting acetylcholinesterase (AChE), the enzyme that destroys acetylcholine after it has been secreted into t...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2001
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8078195/ https://ncbi.nlm.nih.gov/pubmed/11405996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001499 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|